Skip to main content
Fig. 7 | Lipids in Health and Disease

Fig. 7

From: Saturated and mono-unsaturated lysophosphatidylcholine metabolism in tumour cells: a potential therapeutic target for preventing metastases

Fig. 7

Manipulation of the LysoPC plasma levels and its effects on metastatic spreading: a: Luciferase activity of mouse lung homogenates from mice without tumour cell injection (healthy control mice, n = 5) and mice injected with B16.F10 tumour cells receiving different treatments: mice receiving supplemented chow starting one month before tumour cell injection (EPC3pro, n = 4) and starting after tumour cell injection (EPC3ther, n = 5); mice with LysoPC s.c. injections (n = 5) and tumour control mice (no therapy, n = 5). b: Mean values ± SD of plasma LysoPC levels before (n = 9) and after (n = 7) i.v. injection of liposomes, plasma LysoPC levels determined by HPLC MS/MS analysis

Back to article page

Lipids in Health and Disease

ISSN: 1476-511X